Pyrls.com Expands Drug Information Access with Over 1,700 AHFS Monographs

As a part of its Launch week, Pyrls.com has integrated over 1,700 AHFS drug monographs into its platform, providing healthcare providers with comprehensive, evidence-based drug information directly accessible through the site and mobile app.

How It Works: The AHFS monographs are integrated into Pyrls’ existing interface, allowing users to search for drug information, compare formulations, and understand clinical uses without needing external resources.

Here are a few ways the new monographs can be used:

• Quickly locate common side effects of oncology medications, such as Keytruda (pembrolizumab) Navigate the complex landscape of off-label drug uses, e.g. tricyclic antidepressants
• Obtain essential counseling points for specialty medications like Skyrizi (risankizumab), Tremfya (guselkumab), or Otezla (apremilast)
• Compare drug formulations using detailed charts, such as a side-by-side analysis of diltiazem preparations

In Practice:

Healthcare providers can now utilize Pyrls for immediate access to detailed drug profiles during patient consultations, aiding in accurate medication dispensing, patient education, and therapeutic decision-making. Also, Pharmacies can now choose Pyrls as their preferred Drug Compendia to meet regulatory requirements.

Source: https://www.linkedin.com/posts/get-pyrls_pyrls-now-features-1700-ahfs-drug-monographs-activity-7233881050165211137-_xMy/?utm_source=share&utm_medium=member_desktop

Visit Pyrls.com to learn more.

Pyrls is a proud sponsor of Rx Radio.